Will research peptides get banned?

Some already face action, and lately it has gone against the sellers more often than for them. In April 2026 the FDA took BPC-157, TB-500, and MOTS-c off its Category 2 list, which meant compounding pharmacies (pharmacies that mix their own versions) were told to stop making them. In July 2026 an FDA advisory panel then voted on whether to recommend several of these peptides, including BPC-157 and TB-500, for compounding. The results were mixed and are still working through the process.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of research peptides, the category. What research peptides are, legally and practically, before getting into specific compounds.